Searched for
ENZYME INHIBITOR
In the 1930s, rubber factory workers drank alcohol and suddenly felt sick. It wasn't just a workplace illness, it led to the discovery of Antabuse, helping millions quit drinkingAn accidental discovery in a rubber factory in the 1930s revealed that workers exposed to tetraethylthiuram disulfide experienced severe re...- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Tata group’s Impetis out-licenses arthritis and autoimmune drugs to VyomeIn a significant move for medical innovation, Impetis Biosciences, a subsidiary of Tata group, has teamed up with Vyome Holdings from the U...
- Scientists from India, Russia, Brazil, South Africa will collaborate on Covid researchThe consolidation of efforts, knowledge and experience of scientists and specialists from different areas will lead to the optimisation of ...
- New post-infection treatment for COVID-19 identifiedThese protease inhibitors are a class of antiviral drugs that prevent viral reproduction by selectively binding to viral enzymes and blocki...
- Eli Lilly receives permission to conduct Phase 3 clinical trials for Covid treatmentThe Subject Expert Committee (SEC) that advises the drug regulatory authority on new drugs, vaccines for Covid gave its permission to the c...
- The Covid 'gender' conundrum: Men are more vulnerable to coronavirus due to high levels of 'gateway' moleculeGateway molecule enables novel coronavirus to infect healthy cells.
- Decoded: Why COVID-19 is more severe in older people than youngThis study reported more severe disease outcomes in patients with hypertension.
- Zydus & CMS enter pact for Desidustat in Greater ChinaThe agreement is for Desidustat, a novel oral HIF-PH inhibitor for the treatment of anemia in patients with Chronic Kidney Disease (CKD) no...
- Glenmark Pharma launches anti-diabetes drug Remogliflozin in IndiaGlenmark said it will commercialise Remogliflozin in India under the brand names 'Remo' and 'Remozen'.
- Suffering from type 2 diabetes? New treatments can help control blood glucose levelOn World Diabetes Day, here's a list of new medications that will make life simpler for diabetics.
- What’s antacid got to do with India’s IIP growth?Digestive enzymes, antacids, and PPIs led the dominant item group of five that contributed positively to the overall IIP growth.
- Modi should thank India's chronic indigestion for factory growthWhat drove this spike in factory output? Digestive enzymes and antacids topped the list of dominant item groups which positively contribute...
- HIV drugs may take a toll on brain, says studyLife-changing medicines for HIV patients may lead to forgetfulness, confusion and behavioural changes.
- New compound helps diabetic wound heal fasterNon-healing chronic wounds are a major complication of diabetes, which result in more than 70,000 lower-limb amputations in the US alone ea...
- New drugs that may cure baldness foundThe drugs inhibit a family of enzymes inside hair follicles that are suspended in a resting state, restoring hair growth.
- Cancer-fighting drugs might stop malaria earlyMalaria is caused by a single-celled parasite called Plasmodium that spreads from person to person through mosquito bites.
- New drug for inherited cancer identifiedScientists have identified a new drug that can potentially treat an inherited form of cancer that has no cure.
- Immortality cap: Ageing may die out one dayResearch for which 3 US scientists have been awarded Nobel prize in medicine, has huge implications for the future of humankind.
- Novartis ties up with USV to market Galvus in IndiaNovartis has tied up with leading healthcare company - USV - to market its anti-diabetic product Galvus.
Load More
